Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
A2A Pharmaceuticals, Inc.
10% owner at Biomea Fusion. Filing since 17 Sep 2021.
CIK 0001859061
Company
Date
Role
Action
Shares
Amount
Of holding
BMEA
Biomea Fusion, Inc.
1 Jun 2023
10% owner
Sold at will
50,000
$1.73M
1.4%
BMEA
Biomea Fusion, Inc.
31 May 2023
10% owner
Sold at will
75,000
$2.54M
2.1%
BMEA
Biomea Fusion, Inc.
12 May 2023
10% owner
Sold at will
25,000
$846.00K
0.7%
BMEA
Biomea Fusion, Inc.
9 May 2023
10% owner
Sold at will
150,000
$5.18M
3.9%
BMEA
Biomea Fusion, Inc.
8 May 2023
10% owner
Sold at will
100,000
$3.40M
2.6%
BMEA
Biomea Fusion, Inc.
20 Apr 2023
10% owner
Sold at will
200,000
$5.82M
4.9%
BMEA
Biomea Fusion, Inc.
31 Mar 2023
10% owner
Bought
200,000
$6.25M
5.1%
BMEA
Biomea Fusion, Inc.
16 Aug 2022
10% owner
Sold, plan not stated
30,684
$425.65K
0.7%
BMEA
Biomea Fusion, Inc.
21 Jul 2022
10% owner
Sold, plan not stated
34,658
$388.52K
0.8%
BMEA
Biomea Fusion, Inc.
24 Jun 2022
10% owner
Sold, plan not stated
34,658
$407.58K
0.8%
BMEA
Biomea Fusion, Inc.
17 Sep 2021
10% owner
Bought
34,658
$379.85K
0.8%
11 decisions on file.
